- Home
- SEZL vs INSP Comparison
SEZL vs INSP Comparison
Compare SEZL & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SEZL | INSP |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Financial Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.3B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | SEZL | INSP |
|---|---|---|
| Price | $67.45 | $81.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 16 |
| Target Price | $119.25 | ★ $133.07 |
| AVG Volume (30 Days) | 659.4K | ★ 1.2M |
| Earning Date | 02-24-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 104.61 | 34.77 |
| EPS | ★ 3.24 | 1.48 |
| Revenue | $418,632,890.00 | ★ $882,622,000.00 |
| Revenue This Year | $68.80 | $15.15 |
| Revenue Next Year | $25.53 | $10.98 |
| P/E Ratio | ★ $20.85 | $53.79 |
| Revenue Growth | ★ 88.74 | 16.81 |
| 52 Week Low | $24.86 | $70.77 |
| 52 Week High | $186.74 | $203.12 |
Technical Indicators
Market Signals| Indicator | SEZL | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 47.07 | 33.81 |
| Support Level | $64.74 | $77.75 |
| Resistance Level | $69.40 | $97.52 |
| Average True Range (ATR) | 4.34 | 5.73 |
| MACD | -0.84 | -1.20 |
| Stochastic Oscillator | 20.90 | 12.21 |
Price Performance
Historical ComparisonAbout SEZL Sezzle Inc.
Sezzle Inc is a financing institution that offers technology-driven payment platform. It allows customers to split their purchase into four installments and pay over 6 weeks with only the first payment due at the time of purchase. Companies operations comprise one reportable segment, the majority of which derives revenue from payment processing platform in North America.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.